African Stock ExchangesΞ

NEIMETH - Neimeth International Pharma

Twitter · Facebook
NEIMETH on Nigerian Stock Exchange. Stock analysis for Neimeth International Pharma including share price chart, dividend and company profile.Stock summary for NEIMETH on the Nigerian Stock Exchange

Neimeth International Pharmaceuticals Plc is the resultant company from the management-buy-out of the 60% equity holding of Pfizer Inc. in Pfizer Products Plc. This management-buy-out took place in May 1997 when Pfizer Inc., in pursuit of its global repositioning strategy, divested 60% equity in Pfizer Products Plc. in favour of the existing management. Before the brand name Neimeth International Pharmaceuticals Plc, the company had operated in Nigeria for 40 years, manufacturing, marketing, and distributing Pfizer brands of pharmaceutical and veterinary products in tablets, capsules, ointment/cream, powder, injectables, and oral liquid forms.

NEIMETH0.98 ▴0.06 (6.52%) 4 days ago
Last Trading ResultsGrowth & Valuation
Opening Price:0.96Earnings Per Share:-0.13
Day's Low Price:0.92Price/Earning Ratio:--
Day's High Price:1.00Dividend Per Share:--
Traded Volume:11,530,774Dividend Yield:--
Number of Deals:149Shares Outstanding:1,726.51m
Value/Turnover:11.04mMarket Capitalization:1.69b

Monetary values are quoted in Nigerian Naira (NGN) unless otherwise stated

NEIMETH Market Performance

NEIMETH currently ranks 37th on the Nigerian Stock Exchange in terms of returns to investors with a year-to-date gain of 25.64%. Following NEIMETH are DIAMONDBNK (25.56%), UNILEVER (22.83%), and LINKASSURE (22%). Shareholders are anxiously awaiting when Neimeth International Pharma will announce dividends to see whether they have gained something or not. Below is the historical trading trend of NEIMETH, covering up to the last 10 trading sessions of activity.


Profile of Neimeth International Pharma

Neimeth International Pharma operates in the Health Care sector, specifically, the Pharmaceuticals industry—according to the reverse Industry Classification Benchmark (ICB) taxonomy. The company's board of directors is composed of 11 members whose names are listed below.

  1. Dr. A. B. C. Orjiako
  2. E. P. Ekunno
    Chief Executive Officer
  3. Christopher U. Mmeje
    Finance Director
  4. Mazi Sam I. Ohuabunwa
    Non-Executive Director
  5. Godwin E. Omene
    Non-Executive Director
  6. Godfrey N. Ohuabunwa
    Non-Executive Director
  7. A. O. Balogun
    Non-Executive Director
  8. Elijah N. Sokomba
    Non-Executive Director
  9. Maurice M. Iwu
    Non-Executive Director
  10. Thomas Tunbosun Osubu
    Non-Executive Director
  11. Sir. Ike Onyechi
    Non-Executive Director
Factsheet of Neimeth International Pharma
Health Care
1 Henry Carr Street, Ikeja Industrial Estate, Ikeja, Lagos 21111, Nigeria

Industrial Stock Market Competitors

Neimeth International Pharma, issuers of the NEIMETH stock on the Nigerian Stock Exchange, have seven market competitors who are also engaged in the Health Care/Pharmaceuticals industry. The table below gives you an overview of their market standing.

SymbolCompanyMkt. Cap.PriceChange
GLAXOSMITHGlaxo Smithkline Consumer24.46b20.45+0.00
MAYBAKERMay & Baker Nigeria4.65b4.74-0.24
FIDSONFidson Healthcare4.13b2.75-0.10
NIG-GERMANNigeria-German Chemicals556.71m3.62+0.00
PHARMDEKOPharma-Deko Plc487.85m2.25+0.07
EVANSMEDEvans Medical Plc366.17m0.50+0.00
AFRIKAfrik Pharmaceuticals12.45m0.50+0.00

Index of African Stock Exchanges:

  1. Botswana Stock Exchange
  2. Ghana Stock Exchange
  3. Malawi Stock Exchange
  4. Nairobi Securities Exchange
  5. Nigerian Stock Exchange
  6. Zimbabwe Stock Exchange

Post a comment

    NOTE: You are replying to 's comment. [Cancel]